Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LXRX | REPL | MXCT | ||
| Company | Lexicon Pharmaceutcl | Replimune Group Inc | Maxcyte Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.5500 | 6.22 | 3.67 | ||
| High | 1.6100 | 6.57 | 3.74 | ||
| Low | 1.5300 | 6.06 | 3.59 | ||
| Last | 1.5800 | 6.42 | 3.71 | ||
| Change | +0.0400 | +0.27 | +0.02 | ||
| % Change | +2.60% | +4.39% | +0.54% | ||
| Volume | 1,271,900 | 603,700 | 340,200 | ||
| 20-Day Average Volume | 2,699,390 | 832,610 | 470,565 | ||
| Previous Close | 1.5400 | 6.15 | 3.69 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.8668 | 6.95 | 3.99 | ||
| 20-Day Raw Stochastic | 6.45% | 24.24% | 18.25% | ||
| 20-Day Relative Strength | 38.14% | 37.33% | 35.65% | ||
| Weighted Alpha | -52.32 | -55.48 | -29.06 | ||
| Today's Opinion | 24% Sell | 100% Sell | 56% Sell | ||
| Previous Opinion | 24% Sell | 100% Sell | 56% Sell | ||
| Last Month's Opinion | 64% Buy | 64% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.24% since 04/19/24 | -0.47% since 04/19/24 | -6.08% since 04/19/24 | ||
| Low | 1.5200 on 04/25/24 | 5.86 on 04/25/24 | 3.59 on 04/26/24 | ||
| High | 1.8575 on 04/22/24 | 6.77 on 04/23/24 | 4.11 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -20.20% since 03/26/24 | -16.51% since 03/26/24 | -14.52% since 03/26/24 | ||
| Low | 1.5200 on 04/25/24 | 5.86 on 04/25/24 | 3.59 on 04/26/24 | ||
| High | 2.4700 on 03/28/24 | 8.46 on 03/28/24 | 4.50 on 03/27/24 | ||
| 3-Month | |||||
| %Chg | -13.19% since 01/26/24 | -17.48% since 01/26/24 | -26.24% since 01/26/24 | ||
| Low | 1.5200 on 04/25/24 | 5.86 on 04/25/24 | 3.59 on 04/26/24 | ||
| High | 3.7300 on 02/16/24 | 9.20 on 03/11/24 | 5.29 on 01/31/24 | ||
| 6-Month | |||||
| %Chg | +37.39% since 10/26/23 | -56.15% since 10/26/23 | +25.34% since 10/26/23 | ||
| Low | 0.9200 on 11/10/23 | 5.86 on 04/25/24 | 2.84 on 10/30/23 | ||
| High | 3.7300 on 02/16/24 | 15.18 on 10/27/23 | 5.55 on 01/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 389,054 | 394,111 | 387,309 | ||
| Shares Outstanding, K | 246,237 | 61,388 | 104,396 | ||
| Annual Sales | 1,200,000 | 0 | 41,290,000 | ||
| Annual Net Income | -177,120,000 | -174,280,000 | -37,920,000 | ||
| Last Quarter Sales | 700,000 | 0 | 15,660,000 | ||
| Last Quarter Net Income | -49,760,000 | -51,120,000 | -5,280,000 | ||
| 60-Month Beta | 1.27 | 1.21 | 1.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 03/11/24 | -0.77 on 02/08/24 | -0.05 on 03/12/24 | ||
| Latest Earnings Date | 05/07/24 | 05/16/24 | 05/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||